Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Artificial Beta Cells Shown to Produce Insulin as Needed

A biomedical engineering team developed artificial beta cells that in animal tests perform similar to natural cells in the pancreas to produce insulin as needed for controlling blood glucose levels. . . . → Read More: Artificial Beta Cells Shown to Produce Insulin as Needed

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Phone-Based Lupus Home Test Kit in Development

A home test kit using smartphone imaging is being created by biomedical engineers to detect kidney inflammation caused by lupus, an autoimmune disorder. . . . → Read More: Phone-Based Lupus Home Test Kit in Development

Online Game Harnessed to Combat Foodborne Toxins

A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops. . . . → Read More: Online Game Harnessed to Combat Foodborne Toxins

Gas-Jet Printing Process Developed for Medications

A team of material scientists and biomedical engineers designed techniques for producing pharmaceuticals on demand by printing drugs as thin films. . . . → Read More: Gas-Jet Printing Process Developed for Medications

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

Synthetic DNA Start-Up Raises $13M in Early Funds

A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds

Risks of E-Cigarette Use, Ingredients Highlighted

Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes. . . . → Read More: Risks of E-Cigarette Use, Ingredients Highlighted

Clinical Trial Okayed for Parkinson’s Drug Implant

A maker of implants for long-term release of drugs to treat chronic diseases says the Food and Drug Administration approved a clinical trial to test its implant for Parkinson’s disease. . . . → Read More: Clinical Trial Okayed for Parkinson’s Drug Implant

Vaccines in Development for Opioid Combinations

Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street. . . . → Read More: Vaccines in Development for Opioid Combinations